Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to 0.28.

  • Integra Lifesciences Holdings' Equity Ratio fell 2396.77% to 0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28, marking a year-over-year decrease of 2396.77%. This contributed to the annual value of 0.38 for FY2024, which is 884.0% down from last year.
  • Integra Lifesciences Holdings' Equity Ratio amounted to 0.28 in Q3 2025, which was down 2396.77% from 0.28 recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Equity Ratio registered a high of 0.46 during Q4 2022, and its lowest value of 0.28 during Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' median Equity Ratio value was 0.42 (recorded in 2023), while the average stood at 0.41.
  • Its Equity Ratio has fluctuated over the past 5 years, first soared by 761.52% in 2022, then tumbled by 2479.46% in 2025.
  • Integra Lifesciences Holdings' Equity Ratio (Quarter) stood at 0.45 in 2021, then grew by 4.14% to 0.46 in 2022, then decreased by 9.49% to 0.42 in 2023, then dropped by 8.84% to 0.38 in 2024, then fell by 25.66% to 0.28 in 2025.
  • Its Equity Ratio stands at 0.28 for Q3 2025, versus 0.28 for Q2 2025 and 0.38 for Q1 2025.